e-ISSN 2329-0072

Logo

Medical
MSM  BR

AmJCaseRep

Get your full text copy in PDF

Beta-blockers in patients following AMI and in the course of supraventricular and ventricular arrhythmias.

Maciej Banach, Andrzej Banyś, Piotr Okoński

Med Sci Tech 2006; 47(2): OT73-77

ID: 881494


The beta-blockers are complex and pharmacological heterogonous group of drugs. Recently some new preparations being characterized by prolonged time of hipotensive activity and metabolic neutrality, have been introduced to clinical practice. Some of them demonstrate direct vasodilating activity, others show beneficial influence on endothelium function and antioxidative characteristics. β-blockers differ with the degree of sympathicomimetic activity, ant their characteristics are determined by fat dissolubility, what influences on biological availability, concentration in serum and ability of penetration to central nervous system. Currently the drugs occupy established position in the therapy of hypertension, heart failure, they play also very important part in patients following acute myocardial infraction (AMI) and in the prevention and treatment of supraventricular and ventricular arrhythmias. (Clin. Exp. Med. Lett. 2006; 47(2):73-77)

Keywords: beta-blockers, Heart Failure, Hypertension, Myocardial Infarction, Supraventricular and ventricular arrhythmias

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree